Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
Haas, Martin
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study. [electronic resource] - Wiener klinische Wochenschrift Feb 2002 - 143-7 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study
0043-5325
Adult
Anticholesteremic Agents--therapeutic use
Antioxidants--adverse effects
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Glomerulonephritis, Membranous--drug therapy
Humans
Kidney Function Tests
Lipid Peroxidation--drug effects
Lovastatin--therapeutic use
Male
Middle Aged
Probucol--therapeutic use
Prospective Studies
Proteinuria--drug therapy
Treatment Outcome
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study. [electronic resource] - Wiener klinische Wochenschrift Feb 2002 - 143-7 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study
0043-5325
Adult
Anticholesteremic Agents--therapeutic use
Antioxidants--adverse effects
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Glomerulonephritis, Membranous--drug therapy
Humans
Kidney Function Tests
Lipid Peroxidation--drug effects
Lovastatin--therapeutic use
Male
Middle Aged
Probucol--therapeutic use
Prospective Studies
Proteinuria--drug therapy
Treatment Outcome